Segui
Mattia Sturlese
Mattia Sturlese
Dipartimento di Scienze del Farmaco
Email verificata su unipd.it
Titolo
Citata da
Citata da
Anno
Molecular architecture and the structural basis for anion interaction in prestin and SLC26 transporters
D Gorbunov, M Sturlese, F Nies, M Kluge, M Bellanda, R Battistutta, ...
Nature communications 5 (1), 3622, 2014
942014
MMsINC: a large-scale chemoinformatics database
J Masciocchi, G Frau, M Fanton, M Sturlese, M Floris, L Pireddu, P Palla, ...
Nucleic Acids Research 37 (suppl_1), D284-D290, 2009
922009
Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53
S Girotto, M Sturlese, M Bellanda, I Tessari, R Cappellini, M Bisaglia, ...
Journal of Biological Chemistry 287 (22), 18738-18749, 2012
852012
Deciphering the complexity of ligand–protein recognition pathways using supervised molecular dynamics (SuMD) simulations
A Cuzzolin, M Sturlese, G Deganutti, V Salmaso, D Sabbadin, A Ciancetta, ...
Journal of chemical information and modeling 56 (4), 687-705, 2016
842016
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
M Pavan, G Bolcato, D Bassani, M Sturlese, S Moro
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1645-1649, 2021
712021
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
G Bolcato, M Bissaro, M Pavan, M Sturlese, S Moro
Scientific reports 10 (1), 20927, 2020
622020
A high-throughput screening identifies MICU1 targeting compounds
G Di Marco, F Vallese, B Jourde, C Bergsdorf, M Sturlese, A De Mario, ...
Cell reports 30 (7), 2321-2331. e6, 2020
612020
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington’s disease
S Leone, C Mutti, A Kazantsev, M Sturlese, S Moro, E Cattaneo, ...
Bioorganic & medicinal chemistry 16 (10), 5695-5703, 2008
602008
Exploring protein-peptide recognition pathways using a supervised molecular dynamics approach
V Salmaso, M Sturlese, A Cuzzolin, S Moro
Structure 25 (4), 655-662. e2, 2017
592017
DockBench: an integrated informatic platform bridging the gap between the robust validation of docking protocols and virtual screening simulations
A Cuzzolin, M Sturlese, I Malvacio, A Ciancetta, S Moro, R Ragno
Molecules 20 (6), 9977-9993, 2015
522015
Iron–sulfur cluster binding by mitochondrial monothiol glutaredoxin-1 of Trypanosoma brucei: molecular basis of iron–sulfur cluster coordination and relevance for parasite …
B Manta, C Pavan, M Sturlese, A Medeiros, M Crispo, C Berndt, ...
Antioxidants & redox signaling 19 (7), 665-682, 2013
482013
The rise of molecular simulations in fragment-based drug design (FBDD): an overview
M Bissaro, M Sturlese, S Moro
Drug Discovery Today 25 (9), 1693-1701, 2020
462020
Identification of a novel Mcl-1 protein binding motif
WJ Placzek, M Sturlese, B Wu, JF Cellitti, J Wei, M Pellecchia
Journal of Biological Chemistry 286 (46), 39829-39835, 2011
442011
Identification of a novel Mcl-1 protein binding motif
WJ Placzek, M Sturlese, B Wu, JF Cellitti, J Wei, M Pellecchia
Journal of Biological Chemistry 286 (46), 39829-39835, 2011
442011
Combining self-and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2
V Salmaso, M Sturlese, A Cuzzolin, S Moro
Journal of computer-aided molecular design 32, 251-264, 2018
342018
Polyamine-based thiols in trypanosomatids: evolution, protein structural adaptations, and biological functions
B Manta, M Bonilla, L Fiestas, M Sturlese, G Salinas, M Bellanda, ...
Antioxidants & Redox Signaling 28 (6), 463-486, 2018
332018
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy
F Rodriguez-Enriquez, MC Costas-Lago, P Besada, M Alonso-Pena, ...
Bioorganic Chemistry 104, 104203, 2020
322020
AquaMMapS: an alternative tool to monitor the role of water molecules during protein–ligand association
A Cuzzolin, G Deganutti, V Salmaso, M Sturlese, S Moro
ChemMedChem 13 (6), 522-531, 2018
282018
Targeting protein kinase CK1δ with riluzole: could it be one of the possible missing bricks to interpret its effect in the treatment of ALS from a molecular point of view?
M Bissaro, S Federico, V Salmaso, M Sturlese, G Spalluto, S Moro
ChemMedChem 13 (24), 2601-2605, 2018
272018
Synthesis, biological evaluation and molecular modeling studies of phthalazin-1 (2 H)-one derivatives as novel cholinesterase inhibitors
N Vila, P Besada, D Viña, M Sturlese, S Moro, C Terán
RSC advances 6 (52), 46170-46185, 2016
262016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20